Infection after orthotopic liver transplantation:: analysis of the first 120 consecutive cases

被引:6
作者
Montejo, M [1 ]
Valdivielso, A [1 ]
Suárez, MJ [1 ]
Testillano, M [1 ]
Bustamante, J [1 ]
Gastaca, M [1 ]
Campo, M [1 ]
Errazti, G [1 ]
Pérdigo, K [1 ]
Aguirrebengoa, K [1 ]
de Zárate, PG [1 ]
de Urbina, JO [1 ]
机构
[1] Hosp de Cruces, Unidad Enfermedades Infecciosas, Bilbao, Spain
来源
REVISTA CLINICA ESPANOLA | 2000年 / 200卷 / 05期
关键词
orthotopic liver transplantation; infectious complications; tuberculosis;
D O I
10.1016/S0014-2565(00)70623-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To report the infectious complications and presentation time of the first 120 consecutive liver transplants performed at our institution. Methods. Prospective study of infectious complications among 120 consecutive adult patients who received orthotopic liver transplantation at Hospital de Cruces, from February 1996 to November 1998. Two patients received a renal transplant concomitantly. The same surveillance protocols were used for all patients and the criteria used to define infections were those reported by other authors. Results. The group consisted of 120 patients, 95 males and 25 females. The age ranged from 20 and 66; years (mean: 54 +/- 9 years). The indications for transplantation included alcoholic cirrhosis (47%), HCV cirrhosis (20%), hepatocellular carcinoma (17.5%), fulminant hepatitis (6%), primary biliary cirrhosis (2.5%) and miscellaneous conditions (7%). Three patients required retransplantation. Acute rejection was histologically diagnosed in 38 patients (31%). None of the patients had corticosteroid-resistant rejection. Fifty-one patients (42.5%) developed 76 episodes of severe infection, which included: 48 episodes of bacterial infection among 33 patients (27.5%), tuberculosis in 7 patients (6%), 9 episodes of fungal infection among 8 patients (7%) and cytomegalovirus (CMV) infection among 8.5% of patients. No patient developed Pneumocystis carinii pneumonia. Fifteen (12.5%) patients died: six (12.5%) with active infection, and in four of them the infection was considered the cause of death. Conclusions. Infection rates due to bacteria and fungi were similar to those reported in the literature. A high rate of tuberculosis was found, which possible correlated with the high incidence of this disease in the general population. The low incidence of CMV infection was probably due to the preemptive therapy with gancyclovir. Trimethoprimsulfamethoxazol prophylaxis against Pneumocystis carinii was highly effective.
引用
收藏
页码:245 / 251
页数:7
相关论文
共 49 条
[1]   Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain [J].
Aguado, JM ;
Herrero, JA ;
Gavalda, J ;
TorreCisneros, J ;
Blanes, M ;
Rufi, G ;
Moreno, A ;
Gurgui, M ;
Hayek, M ;
Lumbreras, C ;
Morales, JM ;
Pahissa, A ;
Margerit, C ;
Prada, JL ;
Kindelan, JM ;
Ros, F ;
Pallardo, LM ;
Carratala, J ;
Gudiol, F ;
Gonzalez, J ;
Vilardell, J ;
Guirado, L ;
Rabella, N .
TRANSPLANTATION, 1997, 63 (09) :1278-1286
[2]   RISK-FACTORS FOR SYSTEMIC FUNGAL-INFECTIONS IN LIVER-TRANSPLANT RECIPIENTS [J].
BRIEGEL, J ;
FORST, H ;
SPILL, B ;
HAAS, A ;
GRABEIN, B ;
HALLER, M ;
KILGER, E ;
JAUCH, KW ;
MAAG, K ;
RUCKDESCHEL, G ;
PETER, K .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (05) :375-382
[3]  
CASTALDO P, 1991, ARCH SURG-CHICAGO, V126, P149, DOI 10.1001/archsurg.1991.01410260033005
[4]   Risk of tuberculosis in tuberculin skin test-positive liver transplant patients [J].
Chaparro, SV ;
Montoya, JG ;
Keeffe, EB ;
Rhee, JT ;
Small, PM .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :207-208
[5]   RISK-FACTORS FOR INVASIVE FUNGAL-INFECTIONS COMPLICATING ORTHOTOPIC LIVER-TRANSPLANTATION [J].
COLLINS, LA ;
SAMORE, MH ;
ROBERTS, MS ;
LUZZATI, R ;
JENKINS, RL ;
LEWIS, WD ;
KARCHMER, AW .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :644-652
[6]  
COLONNA JO, 1988, ARCH SURG-CHICAGO, V123, P360
[7]  
COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407
[8]   Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [J].
Gane, E ;
Saliba, F ;
Valdecasas, GJC ;
OGrady, J ;
Pescovitz, MD ;
Lyman, S ;
Robinson, CA .
LANCET, 1997, 350 (9093) :1729-1733
[9]  
GEORGE DL, 1991, REV INFECT DIS, V13, P387
[10]   A MULTIVARIATE-ANALYSIS OF RISK-FACTORS FOR CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS [J].
GORENSEK, MJ ;
CAREY, WD ;
VOGT, D ;
GOORMASTIC, M .
GASTROENTEROLOGY, 1990, 98 (05) :1326-1332